These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22432556)

  • 1. Association of furosemide dose with clinical status, left ventricular dysfunction, natriuretic peptides, and outcome in clinically stable patients with chronic systolic heart failure.
    Dini FL; Guglin M; Simioniuc A; Donati F; Fontanive P; Pieroni A; Orsini E; Caravelli P; Marzilli M
    Congest Heart Fail; 2012; 18(2):98-106. PubMed ID: 22432556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiparametric clinical and echocardiographic score to risk stratify patients with chronic systolic heart failure: derivation and testing.
    Fontanive P; Miccoli M; Simioniuc A; Angelillis M; Di Bello V; Baggiani A; Bongiorni MG; Marzilli M; Dini FL
    Echocardiography; 2013 Nov; 30(10):1172-9. PubMed ID: 23742144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining blood flow and tissue Doppler imaging with N-terminal pro-type B natriuretic peptide for risk stratification of clinically stable patients with systolic heart failure.
    Dini FL; Rosa GM; Fontanive P; Santonato V; Napoli AM; Ciuti M; Di Bello V
    Eur J Echocardiogr; 2010 May; 11(4):333-40. PubMed ID: 20051423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure.
    Gaborit F; Bosselmann H; Tønder N; Iversen K; Kümler T; Kistorp C; Sölétormos G; Goetze JP; Schou M
    BMC Cardiovasc Disord; 2015 Aug; 15():92. PubMed ID: 26289429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I-II systolic heart failure.
    Dini FL; Fontanive P; Buralli S; Panicucci E; Andreini D; Conti U; De Tommasi SM
    Int J Cardiol; 2009 Aug; 136(2):144-50. PubMed ID: 18649955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furosemide Prescription During the Dry State Is a Predictor of Long-Term Survival of Stable, Optimally Medicated Patients With Systolic Heart Failure.
    Sargento L; Simões AV; Longo S; Lousada N; Reis RP
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):256-263. PubMed ID: 27784799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
    Dini FL; Ghio S; Klersy C; Rossi A; Simioniuc A; Scelsi L; Genta FT; Cicoira M; Tavazzi L; Temporelli PL
    Int J Clin Pract; 2013 Jul; 67(7):656-64. PubMed ID: 23758444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography.
    Miglioranza MH; Gargani L; Sant'Anna RT; Rover MM; Martins VM; Mantovani A; Weber C; Moraes MA; Feldman CJ; Kalil RA; Sicari R; Picano E; Leiria TL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1141-51. PubMed ID: 24094830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
    Bhardwaj A; Rehman SU; Mohammed AA; Gaggin HK; Barajas L; Barajas J; Moore SA; Sullivan D; Januzzi JL
    Am Heart J; 2012 Nov; 164(5):793-799.e1. PubMed ID: 23137512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure.
    Bonfils PK; Damgaard M; Taskiran M; Goetze JP; Norsk P; Gadsbøll N
    Eur J Heart Fail; 2010 Sep; 12(9):995-1001. PubMed ID: 20615919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study.
    Gaggin HK; Mohammed AA; Bhardwaj A; Rehman SU; Gregory SA; Weiner RB; Baggish AL; Moore SA; Semigran MJ; Januzzi JL
    J Card Fail; 2012 Aug; 18(8):626-34. PubMed ID: 22858078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.